In response to a variety of hormonal, mechanical or pathological stimuli cultured neonatal ventricular myocytes exhibit many of the features of hypertrophy in vivo. The development of the hypertrophic phenotype is characterised by: (i) an increase in cell size in the absence of cell division, (ii) an increase in the assembly of contractile proteins into sarcomeric units and (iii) characteristic changes in gene expression. These include the rapid induction of a programme of immediate-early genes, including the c-fos, c-jun and Egr-l genes, upregulation of a number of constitutively expressed proteins involved in muscle contraction such as ventricular myosin light chain-2 and cardiac a-actin and re-expression of genes normally only expressed during the embryonic stage of ventricular development such as atrial natriuretic factor (ANF), D-myosin heavy chain and skeletal muscle a-actin (SkA) [l].
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The intracellular signalling pathways involved in the development of cardiac hypertrophy are still incompletely understood. However, our recent evidence has suggested that activation of the extracellular-regulated kinase (ERK) members of the mitogen-activated protein kinase (MAPK) family may be involved [2-61. ERKs are activated by phosphorylation on both Thr and Tyr residues within a conserved TEY motif by MAPK kinases. Activation of ERKs is transient, inactivation following from dephosphorylation by dual specificity phosphothreonine/ phosphotyrosine phosphatases of the MAPK phosphatase-1 (MKP-1) family. In order to investigate the role of ERK activation in the hypertrophic response further, cardiac myocytes were transfected with a plasmid encoding an antisense to MKP-1. Its effects on the expression of luciferase (LUX) reporter constructs for ANF, SkA and c-fos were assayed as a marker of the hypertrophic response.
An antisense vector to MKP-I was constructed by subcloning the cDNA encoding the N-terminal 301 amino acids of the murine 3CH134 (MKP-I) gene into the expression vector pBK-CMV (Stratagene) in the reverse orientation. The LUX reporter genes for ANF, SkA and the c-fos serum response element (SRE-LUX) are described elsewhere [5] .
Ventricular myocytes were isolated from the hearts of 1-2 day old rats as described previously [5] . Myocytes were plated on gelatin-coated 60mm tissue culture dishes at a density of 1 million cells per dish in plating medium (Maintenance medium -DMEM/199 (4:l) containing 10% horse serum and 5% FCS) and were maintained at 37°C in a humidified atmosphere of 5% CO,. Twenty hours after plating and 4 h before transfection, medium was changed to 4 mls maintenance medium containing 4% horse serum. Plasmids were diluted in 0.25 M CaCI, and an equal volume of 50 mM N,N-Bis(2-hydroxyethyl)-2-aminoethanesulfonic acid (BES, pH 6.9), 280 mM NaC1, 1.5 mM N%HPO, was added. After 20 min, 1 ml of this suspension (containing 5 pg LUX reporter plasmid and 1 pg of MKP-I antisense plasmid or pBK-CMV control) was added to each plate. After overnight transfection, cells were washed once with 10% horse serum in maintenance medium and twice with maintenance medium before being incubated in maintenance medium. Hypertrophic agonists were added to final concentrations as indicated. After 48 h, myocytes were washed three times with ice-cold phosphatebuffered saline (PBS) and extracted on ice with 0.1 M potassium phosphate (pH7.9), 0.5% (v/v) Triton X-100, 1 mM dithiothreitol (0.4 ml) for 15 min. Luciferase activity was assayed by the addition of 30 p1 of extract to 100 mM Tricine (PH 7.8), 10 mM MgSO,, 2 mM EDTA, 75 mM luciferin and 5.5 mM ATP (500 p1). Light emitted was quantitated in an LKB 1219 RackBeta liquid scintillation counter with the photomultipliers set out of coincidence. Results are presented as the mean f. SEM of experiments on 3-5 separate preparations of myocytes.
In the absence of agonists ANF-, SkA-and c-fos-SRE dependent promoter activity was increased 1.3 to 3.6-fold by the expression of MKP-I antisense compared with the backbone vector pBK-CMV (Table 1) . This suggests that basal levels of MKP-1 may inhibit gene expression in the cardiac myocyte. MKP-1 antisense also enhanced reporter gene expression in the presence of 10 pM phenylephrine (PE), 0.5 nM endothelin-1 (ET-I) or 50 nM TPA, concentrations at which these hypertrophic agonists are submaximally effective (Table 1 ).
In conclusion both basal and agonist-induced cardiac gene expression can be enhanced by expression of an antisense construct to MKP-I. This suggests that endogenous MKP-1 acts to reduce basal cardiac gene expression and therefore to enhance the sensitivity to activation by agonists. These results also provide further evidence that activation of MAPK is an important step in the establishment of the hypertrophic phenotype.
